GC Wealth Management RIA’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$429K Sell
815
-127
-13% -$71.2K 0.02% 353
2026
Q1
$529K Buy
942
+7
+0.7% +$4.49K 0.02% 342
2025
Q4
$633K Sell
935
-1,355
-59% -$923K 0.02% 315
2025
Q3
$1.46M Buy
2,290
+1,326
+138% +$805K 0.05% 255
2025
Q2
$517K Buy
+964
New +$461K 0.04% 319

Other funds holding IDXX

GC Wealth Management RIA's IDXX Position: Q2 2026 in Review

GC Wealth Management RIA reduced its Idexx Laboratories (IDXX) stake by 13% in Q2 2026, selling an estimated $71.2K and leaving 815 shares worth $429K. The position accounts for 0.02% of the portfolio, ranked #353.

GC Wealth Management RIA first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.46M in Q3 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • GC Wealth Management RIA held 815 shares of Idexx Laboratories worth $429K as of Q2 2026.
  • GC Wealth Management RIA sold 127 Idexx Laboratories shares in Q2 2026, an estimated $71.2K.
  • Idexx Laboratories made up 0.02% of GC Wealth Management RIA's portfolio in Q2 2026, its #353 holding.
  • GC Wealth Management RIA first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • GC Wealth Management RIA's Idexx Laboratories position peaked at $1.46M in Q3 2025.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.